Answers are grounded in this paper and cite their sources.
Difficult decisions as to whether to provide or withhold drug therapy to patients are needed to be made on a daily basis. These decisions should be based on carefully designed and constructed pharmacoeconomic models, with explicit and justifiable parameter values, validated by publication in peer-reviewed literature. This review describes and evaluates the common types of pharmacoeconomic models, modelling approaches and methods. It also discusses model quality, validity and usefulness.
No takes yet. Share an insight, caveat, or question.
Joel W. Hay (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: